Company Filing History:
3 out of 321 
2 out of 19 
Years Active: 2013-2015
Title: Kyeong-Eun Jung: Innovator in Pharmaceutical and Nucleotide Oligomer Technologies
Introduction
Kyeong-Eun Jung is a notable inventor based in Anyang-si, South Korea. He has made significant contributions to the fields of pharmaceuticals and biotechnology, holding a total of four patents. His work focuses on innovative solutions for cancer treatment and the efficient synthesis of nucleotide oligomers.
Latest Patents
One of Kyeong-Eun Jung's latest patents is a pharmaceutical composition for treating cancer. This invention provides a composition that includes deoxyribonucleic acids (DNA) for encoding small interfering RNA (siRNA) that targets the FLJ25416 gene. The siRNA, antisense RNA, and short hairpin RNA (shRNA) inhibit the expression of this gene, which is known to be expressed in cancer cells, thereby offering a novel anti-cancer agent.
Another significant patent involves a method for preparing nucleotide oligomers. This method includes coupling a nucleotide dimer or trimer to a nucleoside attached to solid supports, followed by sequentially coupling nucleotide monomers. The resulting nucleotide oligomers have 15-20% higher purity than those produced by conventional methods, enabling efficient and cost-effective synthesis.
Career Highlights
Kyeong-Eun Jung has worked with prominent organizations such as the Korea Research Institute of Bioscience and Biotechnology and St Pharm Co., Ltd. His experience in these institutions has allowed him to develop and refine his innovative ideas in biotechnology and pharmaceuticals.
Collaborations
Kyeong-Eun Jung has collaborated with talented individuals in his field, including Moon Hee Kim and Misun Won. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Kyeong-Eun Jung is a distinguished inventor whose work in cancer treatment and nucleotide synthesis has the potential to make a significant impact in the medical and scientific communities. His innovative patents reflect his dedication to advancing biotechnology and pharmaceuticals.